Trials / Terminated
TerminatedNCT00867789
Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department
Trimethoprim-sulfamethoxazole Versus Placebo in the Treatment of Cutaneous Abscesses in the Emergency Department
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Children's Mercy Hospital Kansas City · Academic / Other
- Sex
- All
- Age
- 3 Months – 17 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if there is a difference between an antibiotic, trimethoprim-sulfamethoxazole versus placebo in healing outcomes of soft tissue abscesses following incision and drainage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trimethoprim-sulfamethoxazole | 10mg/kg/day (based on trimethoprim component), divided twice daily for ten days (maximum dose: 160mg (TMP component) per dose) |
| DRUG | Sugar pill | 10mg/kg/day divided twice daily for ten days. Placebo liquid will contain simple syrup, lactose powder, grape flavor, and food coloring. Placebo capsules will contain lactose powder. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2009-03-24
- Last updated
- 2021-01-26
- Results posted
- 2021-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00867789. Inclusion in this directory is not an endorsement.